Animal Models and Retroviral Vaccines section (AMRVS) Retrovirus Assay, Reagent, and Viral Stock Preparation Support

The National Institutes of Health, National Cancer Institute, Center for Cancer Research, Vaccine Branch, requires laboratory services for immunological assays, virological assays, and the preparation of reagents and viral stocks. This requirement supports the Animal Models and Retroviral Vaccines section and the Retroviral Vaccines Branch in their ongoing research efforts. Classified under NAICS 541380 Testing Laboratories and Services and PSC Q301 MEDICAL- LABORATORY TESTING, this acquisition is conducted as a combined synopsis/solicitation for commercial services using simplified procedures. One single-award Indefinite Delivery Indefinite Quantity contract is anticipated to result from this solicitation.

The procurement is identified by solicitation number 75N91024Q00011 and is managed by Contract Specialist John Russell. Performance will take place in the United States, and the solicitation incorporates provisions through Federal Acquisition Circular 2024-06. The solicitation package includes 10 attachments, such as an amended task order statement of work, an IDIQ price schedule, and a question-and-answer response spreadsheet. Recent amendments to the notice revised the estimated period of performance for the initial task orders while maintaining all other terms and conditions.

Responses to this Request for Quote are due by January 31, 2024. This announcement serves as the sole solicitation for these services, which are intended to meet the technical needs of the National Cancer Institute's Vaccine Branch. All technical requirements and response instructions are detailed within the official solicitation and its accompanying documentation, which were first published on December 7, 2023, and last updated on January 26, 2024.